Oral Presentation Advances in Neuroblastoma Research Congress 2016

Molecular risk stratification of neuroblastoma patients - using RNA, DNA, or both? (#71)

Matthias Fischer 1
  1. University Children's Hospital of Cologne, Cologne, Germany

Not required